Loren Data's SAM Daily™

FBO DAILY ISSUE OF MARCH 07, 2003 FBO #0460
SOLICITATION NOTICE

A -- Development of Hepatits C Virus

Notice Date

3/5/2003
 

Notice Type

Solicitation Notice
 

Contracting Office

Department of Health and Human Services, National Institutes of Health, Nat'l Institute of Diabetes, Digestive, & Kidney Diseases, 2 Democracy Plaza, Suite 700W 6707 Democracy Blvd., MSC 5455, Bethesda, MD, 20892-5455
 

ZIP Code

20892-5455
 

Solicitation Number

NIH-NIDDK-03-894
 

Archive Date

4/17/2003
 

Point of Contact

Patricia Haun, Purchasing Agent, Phone (301) 594-8855, Fax (301) 480-4226,
 

E-Mail Address

haunp@extra.niddk.nih.gov
 

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6 as supplemented with additional information contained in this notice. This procurement is being conducted under Simplified Acquisition Procedures in accordance with FAR Part 13. This solicitation document and incorporated provisions and clauses are those in effect through the September 2001 Federal Acquisition Regulation revision, which includes the consolidation of all Federal Acquisition Circulars through 2001-08. It is the intent of the National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to acquire housing and maintenance services for chimpanzees from Southwest Foundation for Biomedical Research, 7620 NW Loop 410, San Antonio, Texas 78227. These services are for the development of Hepatitis C Virus-like particles as a candidate HCV vaccine in chimpanzees. The services shall include; (1) An AAALAC approved facility for performing the proposed experiments on chimpanzees and housing them for appropriate follow-up; (2) Infect/transfect animals; obtain and store bleedings as well as tissue specimens at appropriate temperatures; perform biopsies, ultrasound and other diagnostic procedures; and obtain other specimens which shall be examined for existence of infection and used for various studies; (3) Perform tests of liver enzyme(s) functions, routine blood and clinical chemistry analyses, and other serological markers and diagnostic tests relating to the development of complications of virus infection such as chronic disease and cancer; (4) Prepare, process and provide evaluation of liver and other tissue specimens including, but not limited to, (histo)pathology of liver to determine disease progression, growth and a variety of viral studies, and perform apheresis to obtain large volume of peripheral lymphocytes and plasma; (5) With approval, send the above tests to established laboratories for determination; (6) House all infected and experimental animals in isolation so that cross-infection or contamination of animals does not occur. Containment of experimental animals in isolation chambers shall be required for the duration of their protocols; and (7) Provide proper veterinary diet, water, electrolytes, and medication for all animals in accordance with the standard prescribed by appropriate Government guidelines and the Project Officer. The service will be for a Base Year with a four (4) year option. The proposed contractor is the only source with the specific chimpanzees that are part of the NIH Primate Facilities, that have been approved for use by the NIH Interagency Animal Model Committee, and that are sanctioned for use by NIDDK. Interested vendors may identify in writing their interest with the capability statement to the Contracting Officer prior to the closing date of this notice. The Government will consider all responses received before the closing date of this announcement. This notice of intent is not a request for competitive proposals. A determination by the Government not to compete this proposed acquisition is based upon responses to this notice and is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. It is anticipated that Request for Quotation (RFQ) NIH-NIDDK-03-894 will be available fifteen (15) days after the publication date of this synopsis. Receipt of quotations will be due ten (10) days after the release of the RFQ. The anticipated award date is April 7, 2003. Request for copies of the RFQ must be in writing and may be faxed to (301) 480-4226. Quotations must be submitted in writing to the National Institute of Diabetes and Digestive and Kidney Disease, 6707 Democracy Blvd., Room 774C, Bethesda, Maryland 20817. Attention: Patricia Haun (301) 594-8855.
 

Place of Performance

Address: 9000 Rockville Pike, Bethesda, MD

Zip Code: 20897

Country: USA
 

Record

SN00270907-W 20030307/030305213427 (fbodaily.com)
 

Source

FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |